[Ductal pancreatic cancer].

Langenbecks Archiv fur Chirurgie. Supplement II, Verhandlungen der Deutschen Gesellschaft fur Chirurgie. Deutsche Gesellschaft fur Chirurgie. Kongress Pub Date : 1990-01-01

F Gall

引用次数: 0

Abstract

In a prospective study of 587 patients tumor resection was possible in 138 (23.5%). Only 91 (65.4%) had been classified as R0-resections. Since 1982 subtotal duodenopancreatectomy has been the preferred method for treating pancreatic head cancer. Operative mortality for the whole series was 6%, for subtotal duodenopancreatectomy only 2%. The 5-year-survival rate for all patients was 2.9% with a mean survival of 4 months. For tumor resection it was 11%, for R0-resection 16%. However, in stages I and II the 5-year-survival was 46% and in stage III with a solitary lymph node metastasis, 30%.

微信好友朋友圈 QQ好友复制链接

本刊更多论文

[导管性胰腺癌]。

在一项587例患者的前瞻性研究中，138例(23.5%)患者的肿瘤切除是可能的。只有91例(65.4%)被归为r0切除。自1982年以来，十二指肠胰次全切除术一直是治疗胰头癌的首选方法。整个系列的手术死亡率为6%，十二指肠胰次全切除术的手术死亡率仅为2%。所有患者的5年生存率为2.9%，平均生存期为4个月。肿瘤切除为11%，r0切除为16%。然而，在I期和II期，5年生存率为46%，而在单发淋巴结转移的III期，5年生存率为30%。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Langenbecks Archiv fur Chirurgie. Supplement II, Verhandlungen der Deutschen Gesellschaft fur Chirurgie. Deutsche Gesellschaft fur Chirurgie. Kongress

自引率

0.00%

发文量

期刊最新文献

[Prevention of thrombosis with low molecular weight heparin and hydroxyethyl starch in general surgery]. [Perioperative chemotherapy of stomach cancer]. [Ductal pancreatic cancer]. [Is there an advantage to neo- or adjuvant chemotherapy in pancreatic cancer?]. [Laser and afterloading therapy: esophageal cancer].